Methods for Decreasing Ocular Toxicity of Antibody Drug Conjugates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120282282A1
SERIAL NO

13439493

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to charged or pro-charged cross-linking moieties and conjugates of cell binding agents and drugs comprising the charged or pro-charged cross-linking moieties and method of using the same to reduce ocular toxicity associated with administration of antibody drug conjugates.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMMUNOGEN INC830 WINTER STREET WALTHAM MA 02451

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chari, Ravi VJ Newton, US 94 914
Lutz, Robert J Wayland, US 36 369

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation